Trial Profile
TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms SELECT-A
- 28 Sep 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by European Clinical Trials Database.
- 22 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2011-002145-35).
- 14 Jun 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.